Concepedia

Randy W. Jackson

RW

12

Publications

827

Citations

12

H-Index

1992

Active since

Affiliations

VenatoRx Pharmaceuticals (United States)(Current)

University of California, Irvine

Irvine University

University of North Texas

University of Siena

Randy W. Jackson is an author at VenatoRx Pharmaceuticals (United States) specializing in drug discovery, medicine, and biochemistry.

Top concepts

Publications per year

1992–2021

12

Publications

12

Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections

Bin Liu, Robert E. Lee Trout, Guo‐Hua Chu et al. · Journal of Medicinal Chemistry · 2019 · 281 citations · Full text

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in <i>Enterobacterales</i> and Pseudomonas aeruginosa

Jodie C. Hamrick, Jean‐Denis Docquier, Tsuyoshi Uehara et al. · Antimicrobial Agents and Chemotherapy · 2019 · 204 citations · Full text

Total Synthesis of the Antiparasitic Agent Avermectin B1a

James D. White, Gary L. Bolton, Anura P. Dantanarayana et al. · Journal of the American Chemical Society · 1995 · 90 citations

, , +8

A mild and selective method for the cleavage of tert-butyl esters

Randy W. Jackson · Tetrahedron Letters · 2001 · 43 citations

, , +9

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes

Robert E. Lee Trout, Allison L. Zulli, Eugen F. Mesaros et al. · Journal of Medicinal Chemistry · 2021 · 41 citations · Full text

Rows per page

1–5 of 12